Status:
UNKNOWN
Very Rapid and Rapid Virological Response as Predictors of Response of HCV Tretment
Lead Sponsor:
Assiut University
Conditions:
Predictors of Response to HCV Tretment
Eligibility:
All Genders
Brief Summary
assessment of very rapid virological response and rapid virological response as predictors of response to sofosbuvir and daclatasvir in treatment of cirrhotic and non-cirrhotic patients with HCV, elig...
Detailed Description
Chronic hepatitis C infection (CHC) is a global health problem, with an estimated 120 to 130 million chronic hepatitis C virus (HCV) carriers worldwide Therefore, early recognition and effective manag...
Eligibility Criteria
Inclusion
- Anti HCV positive patients either chronic HCV or liver cirrhosis.
- Detectable HCV RNA by quantitative PCR prior to treatment.
- Naïve patients (not received any HCV treatment regimen before)
Exclusion
- Patients with hepatocellular carcinoma( HCC)
- Patients with combined HBV and HCV
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03480269
Start Date
August 1 2018
End Date
April 30 2020
Last Update
July 6 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.